By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sorrento Therapeutics, Inc. 

San Diego  California    U.S.A.
Phone: n/a Fax: n/a



Company News
Sorrento Therapeutics, Inc. Announces Completion Of Enrollment In The Cynviloq™ Registrational TRIBECA™ Study 1/28/2015 8:25:42 AM
Sorrento Therapeutics, Inc. Provides Status Update On The Cynviloq™ Registrational TRIBECA™ Study 1/12/2015 9:33:39 AM
Conkwest, Sorrento Therapeutics, Inc. And NantWorks Announce Presentation At The 33rd Annual J. P. Morgan Healthcare Conference By Dr. Patrick Soon-Shiong 1/6/2015 11:03:04 AM
Sorrento Therapeutics, Inc. To Present At The 2015 Biotech Showcase And 8th Annual OneMedForum In San Francisco 1/5/2015 8:45:54 AM
Sorrento Therapeutics, Inc. And Conkwest Announce Exclusive Global Collaboration 12/19/2014 7:44:44 AM
Biotech Billionaire Bets $20 Million On Sorrento Therapeutics, Inc. 12/15/2014 7:50:07 AM
Sorrento Therapeutics, Inc. Announces Poster Presentations On Its Anti-C-Met/PD-L1 Bispecific Antibodies And Anti-C-Met-Antibody Drug Conjugate At The 37th Annual San Antonio Breast Cancer Symposium 12/8/2014 9:11:05 AM
Sorrento Therapeutics, Inc. To Present At The 2014 Oppenheimer Healthcare Conference 12/5/2014 12:46:14 PM
Sorrento Therapeutics, Inc. To Present At The 2014 Stifel Healthcare Conference 11/12/2014 9:32:36 AM
Sorrento Therapeutics, Inc. Release: Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel 10/15/2014 8:03:07 AM